A novel synthetic cannabinoid derivative inhibits inflammatory liver damage via negative cytokine regulation. | Mol Pharmacol;64(6): 1334-41, 2003 Dec. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

A novel synthetic cannabinoid derivative inhibits inflammatory liver damage via negative cytokine regulation.

Lavon, Iris; Sheinin, Tatiana; Meilin, Sigal; Biton, Efrat; Weksler, Ayelet; Efroni, Gilat; Bar-Joseph, Avi; Fink, George; Avraham, Ayelet.

Affiliation

Lavon I; Pharmos LTD, Kiryat Weizmann, Bld #13b, Rehovot 76326, Israel. lavoni@netvision.net.il

Mol Pharmacol ; 64(6): 1334-41, 2003 Dec.

Article in En | MEDLINE | ID: mdl-14645663

Subject(s)

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Cannabinoids / Cytokines / Hepatitis, Animal Type of study: Prognostic_studies Limits: Animals Language: En Journal: Mol Pharmacol Year: 2003 Document type: Article Affiliation country:

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Cannabinoids / Cytokines / Hepatitis, Animal Type of study: Prognostic_studies Limits: Animals Language: En Journal: Mol Pharmacol Year: 2003 Document type: Article Affiliation country: